Clinical Trial Update: SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 trial of Sutent (sunitinib) in patients with recurrent or progressive glioblastoma multiforme is being reported. The current status of the trial is li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Glioblastoma Multiforme | Phase 2 | Status: UNKNOWN